The del(7q) subgroup in uterine leiomyomata: Genetic and biologic characteristics

Cancer Genetics and Cytogenetics

Volumn 98, Issue 1, 1997, Pages 69-74

  Xing, Y Polly ^a,b   Powell, W Lee ^a   Morton, Cynthia C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 7Q; CYTOGENETICS; FEMALE; GENE DELETION; GENE MAPPING; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOSAICISM; PRIORITY JOURNAL; UTERUS MYOMA; X CHROMOSOME INACTIVATION;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HUMANS; LEIOMYOMA; UTERINE NEOPLASMS;

EID: 0030800817     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00406-2     Document Type: Article

References (34)

1. Droegemueller W, Herbst AL, Mishell DR, Stenchever MA (1987): Benign gynecology lesions. In: Comprehensive Gynecology. C. V. Mosby, St. Louis, pp. 440-492.
2. Carlson KJ, Nichols DH, Schiff I (1993): Indications for hysterectomy. N Engl J Med 28:856-860.
3. John AH, Martin R (1971): Growth of leiomyomas with estrogen-progesterone therapy. J Reprod Med 6:156-59.
4. Eiletz J, Genz T, Pollow K, Schmidt-Gollwitzer M (1980): Sex steroid levels in serum, myometrium, and fibromyomata in correlation with cytoplasmic receptors and 17b-HSD activity in different age-groups and phases of the menstrual cycle. Arch Gynecol 229:13-28.
5. Otsuka H, Shinohara M, Kashimura M, Yoshida K, Okamura Y (1989): A comparative study of the estrogen receptor ratio in myometrium and uterine leiomyomas. Int J Gynaecol Obstet 29:189-194.
6. Soules MR, McCarty KS Jr. (1982): Leiomyomas: Steroid receptor content, variation within normal menstrual cycles. Am J Obstet Gynecol 143:6-11.
7. Tiltman A (1985): The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Path 4:89-96.
8. Rein MS, Barbieri RL, Friedman AJ (1995): Progesterone: A critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 172:14-18.
9. Nilbert M, Heim S (1990): Uterine leiomyoma cytogenetics. Genes Chromosom Cancer 2:3-13.
10. Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC (1991): Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 77:923-926.
11. Dal Cin P, Moerman P, Deprest J, Brosens I, Van den Berghe H (1995): A new cytogenetic subgroup in uterine leiomyoma is characterized by a deletion of the long arm of chromosome 3. Genes Chromosom Cancer 13:19-20.
12. Schoenberg Fejzo MS, Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, Yoon S-J, Kucherlapati RS, Chada K, Morton CC (1996): Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosom Cancer 17:1-6.
13. Ozisik YY, Meloni AM, Surti U, Sandberg AA (1993): Deletion 7q22 in uterine leiomyoma. Cancer Genet Cytogenet 71:1-6.
14. Sargent MS, Weremowicz S, Rein MS, Morton CC (1994): Translocations in 7q22 define a critical region in uterine leiomyomata. Cancer Genet Cytogenet 77:65-68.
15. Mashal RD, Schoenberg Fejzo MS, Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morton CC, Sklar J (1994): Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosom Cancer 7:1-6.
16. Surti U. Personal communication.
17. Limon J, Dal Cin P, Sandberg AA (1986): Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23:305-317.
18. Mutter GL, Chaponot ML, Fletcher JA (1995): A polymerase chain reaction assay for nonrandom X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol 146:501-508.
19. Ishwad CS, Ferrell RE, Davare J, Meloni AM, Sandberg AA, Surti U (1995): Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas. Genes Chromosom Cancer 14:51-55.
20. Vachon G, Cohen B, Pfeifle C, McGuffin ME, Botas J, Coheb SM (1992): Homeotic genes of the bithorax complex repress limb development in the abdomen of the Drosophila embryo through the target gene Distalless. Cell 71:437-450.
21. Lemieux N, Zhang X-X, Dufort D, Nepveu A (1994): Assignment of the human homologue of the Drosophila Cut homeobox gene (CUTL1) to band 7q22 by fluorescence in situ hybridization. Genomics 24:191-193.
22. Tsui L-C, Donis-Keller H, Grzeschik K-H (1995): Report of the second international workshop on human chromosome 7 mapping 1994. Cytogenet Cell Genet 71:1-13.
23. Miyagi Y, Yasumitsu H, Eki T, Miyata S, Koshikawa N, Hirahara F, Aoki I, Misugi K, Miyazaki K (1996): Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis. Genomics 35:267-268.
24. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia. Elsevier, Holland, New York, pp. 521-524.
25. Le Beau MM, Albain KS, Larson RA, Varduman JW, Davis EM, Blough RR, Golomb HM, Rowley JD (1936): Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndrome for characteristic abnormalities of chromosome No. 5 and 7. J Clin Oncol 3:325-345.
26. Tosi S, Scherer SW, Rambaldi A, Hashim Y, Wainscoat JS, Osborne L, Biondi A, Tsui L-C, Kearney L (1995): Characterization of 7q abnormalities in the human myeloid leukemia cell line GFD8 by fluorescence in situ hybridization (FISH). Cytogenet Cell Genet 71:28.
27. Scherer SW, Poorkj P, Allen T, Kim J, Geshuri D, Nunes M, Soder S, Stephens K, Pagon RA, Patton MA, Berg MA, Donlon T, Rivera H, Pfeiffer RA, Naritomi K, Hughes H, Genvardi M, Gurrieri F, Neri G, Lovrein E, Magenis E, Tsui L-C, Evans JP (1994): Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am J Hum Genet 55:12-20.
28. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K (1995): Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65.
29. Schoenmakers EFPM, Wanschura S, Mois R, Bullerdiek J, Van den Berghe H, Van de Ven WJM (1995): Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors. Nature Genet 10:436-444.
30. Ferrari S, Finelli P, Rocchi M, Blanchi ME (1996): The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics 35:367-371.
31. Wanschura S, Schoenmakers EFPM, Huysmans C, Bartnitzke S, Van de Ven WJM, Bullerdiek J (1996): Mapping of the human HMG2 gene to 4q31. Genomics 31:264-265.
32. Petersen MB, Economou EP, Slaugenhaupt SA, Chakravarti A, Antonarakis SE (1990): Linkage analysis of the human HMG14 gene on chromosome 21 using a GT dinucleotide repeat as polymorphic marker. Genomics 7:136-138.
33. Mitchell AL, Bale AE, Bustin M, Landsman D, Popescu N, McBride OW (1989): Localization of HMG17 gene to chromosome 1p35-36.1. Cytogenet Cell Genet 51:1045.
34. Wanschura S, Schoenmakers EFPM, Huysmans C, Bartnitzke S, Van de Ven WJM, Bullerdiek J (1996): Mapping of the gene encoding the human hepatoma-derived growth factor (HDGF) with homology to the high-mobility group (HMG)-1 protein to Xq25. Genomics 32:298-300.